Podcast Episodes
Back to Search
Medicare's PAMA Problem: Will 2026 Reimbursement Cuts Crush US Diagnostics Innovation?
This episode examines the critical threat facing the U.S. diagnostics industry due to flawed implementation of the Protecting Access to Medicare Act …
6 months, 1 week ago
2026 MedTech M&A Forecast: Blockbuster Deals in Diagnostics & Structural Heart or Continued Caution?
This episode forecasts the state of medical technology mergers and acquisitions for 2026. We analyze whether the industry will see a return to large,…
6 months, 1 week ago
2026 MedTech Forecast: Tariffs, Supply-Chain Nationalism, and Manufacturing Strategy
This episode explores the significant impact that rising tariffs and supply-chain nationalism are projected to have on the medical technology industr…
6 months, 1 week ago
The Great EU MedTech Squeeze: Portfolio Pruning and Consolidation Under MDR/IVDR in 2026
This episode examines the immense pressures facing medical device manufacturers from Europe's Medical Device Regulation (MDR) and In-Vitro Diagnostic…
6 months, 2 weeks ago
FDA's 2026 MDUFA Impact: A Strategic Guide for Small MedTech Companies
This episode delves into the upcoming 2026 Medical Device User Fee Amendments (MDUFA VI) negotiations and their profound impact on the U.S. medtech l…
6 months, 2 weeks ago
The 2026 AI MedTech Challenge: Cracking the Reimbursement Code
This episode explores the prediction that by 2026, the primary obstacle for AI medical devices will shift from technical validation to securing finan…
6 months, 2 weeks ago
Diabetes Tech in 2026: The Battle Between Closed-Loop Innovation and Regulatory Reality
This episode explores the future of the diabetes technology market, examining the critical tension between rapid innovation and foundational regulato…
6 months, 2 weeks ago
Decentralized Diagnostics: Regulatory Pathways for AI-Powered Imaging in 2026
This episode explores the transformative potential of AI-enabled imaging and ultrasound tools designed for non-experts, set to reshape diagnostics by…
6 months, 2 weeks ago
The 2026 Surgical Robotics Shake-Up: FDA Approvals, Specialization, and New Competition
This episode explores the transformative shift in the surgical robotics market, predicting a move away from a single-player monopoly by 2026. We anal…
6 months, 2 weeks ago
FDA's New Cybersecurity Era: Why SBOMs and Secure Architecture are Non-Negotiable for MedTech by 2026
This episode examines how U.S. FDA regulations have repositioned cybersecurity as a core feature of medical devices. We discuss the impact of the Con…
6 months, 2 weeks ago